A. Barber

发表

Adoptive transfer of murine T cells expressing a chimeric‐PD1‐Dap10 receptor as an immunotherapy for lymphoma

A. Lynch, William Hawk, E. Nylen, 2017, Immunology.

NK cell receptors as tools in cancer immunotherapy.

Tong Zhang, A. Barber, C. Sentman, 2006, Advances in cancer research.

Inclusion of Dap10 or 4-1BB costimulation domains in the chPD1 receptor enhances anti-tumor efficacy of T cells in murine models of lymphoma and melanoma.

E. Nylen, A. Barber, Hailey Kintz, 2020, Cellular immunology.

Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors

A. Barber, C. Sentman, Paul Spear, 2013, Oncoimmunology.

and g Microenvironment through IFN-Myeloid Cell Function within the Tumor Chimeric Antigen Receptor T Cells Shape

A. Barber, C. Sentman, Paul Spear, 2012 .

GM-CSF and γ Microenvironment through IFN-Myeloid Cell Function within the Tumor Chimeric Antigen Receptor T Cells Shape

A. Barber, C. Sentman, Paul Spear, 2012 .

Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.

Tong Zhang, A. Barber, C. Sentman, 2007, Cancer research.

Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.

Tong Zhang, A. Barber, C. Sentman, 2006, Cancer research.

NKG2D receptor regulates human effector T-cell cytokine production.

A. Barber, C. Sentman, 2011, Blood.

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.

K. Roby, Tong Zhang, A. Barber, 2007, Cancer research.

Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer12

Tong Zhang, A. Barber, C. Sentman, 2008, The Journal of Immunology.

Human NK cell IFN-γ production is regulated by endogenous TGF-β

Sarah K. Meadows, A. Barber, C. Sentman, 2006 .

Generation of Murine Chimeric Antigen Receptor T Cells for Adoptive T Cell Therapy for Melanoma.

A. Barber, 2021, Methods in molecular biology.

Immunity in Murine Ovarian Cancer Survival and Development of Host Antitumor Receptors Leads to Long-Term Tumor-Free Immunotherapy with Chimeric NKG 2 D

A. Barber, C. Sentman, 2007 .

Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells

A. Barber, K. Meehan, C. Sentman, 2011, Gene Therapy.

Correction: Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity

A. Barber, C. Sentman, 2014, The Journal of Immunology.

Systemic and Perforin Expression to Increase Tumor Cell-and Host-Derived Cytokine Secretion Chimeric NKG 2 D T Cells Require Both T

A. Barber, C. Sentman, 2009 .

Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity12

A. Barber, C. Sentman, 2009, The Journal of Immunology.

Disconnecting the Estrogen Receptor Binding Properties and Antimicrobial Properties of Parabens through 3,5-Substitution.

A. Barber, Andrew Yeagley, Hailey Kintz, 2018, ACS medicinal chemistry letters.

Olive oil varieties cultivated in Morocco reduce reactive oxygen species and cell viability of human cervical cancer cells

Sarah A. Ghali, F. Laziri., A. Barber, 2020 .

Chimeric NKG2D receptor-expressing T cells as an immunotherapy for multiple myeloma.

C. Megli, Tong Zhang, A. Barber, 2008, Experimental hematology.

Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment1

A. Barber, C. Sentman, A. Rynda, 2009, The Journal of Immunology.

MicroenvironmentImmunity within the Ovarian Tumor Eliminate Immunosuppression and Activate Chimeric NKG2D Expressing T Cells

A. Barber, C. Sentman, A. Rynda, 2009 .

Correction: Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer

Tong Zhang, A. Barber, C. Sentman, 2014, The Journal of Immunology.

NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.

A. Barber, E. Whitman, 2015, Molecular immunology.

Costimulation of Effector CD8+ T Cells: Which Receptor is Optimal for Immunotherapy?

A. Barber, 2014 .

Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF

A. Rynda-Apple, A. Barber, C. Sentman, 2012, The Journal of Immunology.

T‐cells expressing a chimeric‐PD1‐Dap10‐CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer

E. Nylen, A. Barber, Geoffrey Parriott, 2020, Immunology.

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity.

A. Gewirtz, A. Barber, J. Cubillos-Ruiz, 2009, The Journal of clinical investigation.

Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.

A. Barber, Z. Szczepiorkowski, K. Meehan, 2008, Cytotherapy.

NKG2D CAR T‐cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors

A. Rynda-Apple, A. Barber, C. Sentman, 2013, Immunology and cell biology.

Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T‐cell differentiation

A. Barber, E. Whitman, Bryan E. McQueen, 2016, Immunology.

Human NK cell IFN-gamma production is regulated by endogenous TGF-beta.

A. Barber, C. Sentman, M. Eriksson, 2006, International immunopharmacology.

Abstract LB148: Gamma delta T cells engineered with a chimeric PD-1 receptor effectively control PD-L1 positive tumors in vitro and in vivo with minimal toxicities

Xiaohong Wang, A. Barber, M. Chiriva-Internati, 2021, Immunology.

Using Biological Organisms as Chemical Sensors: The MicRoboCop Project

A. Barber, Sarah E. G. Porter, Olivia K. Colella, 2018, Journal of Chemical Education.

Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity12

A. Barber, C. Sentman, 2009, The Journal of Immunology.

NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.

A. Barber, E. Whitman, 2015, Molecular immunology.